Copyright
©The Author(s) 2016.
World J Hepatol. Jun 8, 2016; 8(16): 691-702
Published online Jun 8, 2016. doi: 10.4254/wjh.v8.i16.691
Published online Jun 8, 2016. doi: 10.4254/wjh.v8.i16.691
Figure 1 Flow diagram of studies selection.
1Searches conducted with MEDLINE results removed; 2Studies missing key clinical information including clear inclusion and exclusion criteria, clear diagnostic parameters, etc., and studies that investigated subpopulations (e.g., BCS patients requiring liver transplantation, BCS patients without MPN, etc.); 3Studies focused on other categories (e.g., causes of liver failure). BCS: Budd-Chiari syndrome; MPN: Myeloproliferative neoplasms.
- Citation: Shin N, Kim YH, Xu H, Shi HB, Zhang QQ, Colon Pons JP, Kim D, Xu Y, Wu FY, Han S, Lee BB, Li LS. Redefining Budd-Chiari syndrome: A systematic review. World J Hepatol 2016; 8(16): 691-702
- URL: https://www.wjgnet.com/1948-5182/full/v8/i16/691.htm
- DOI: https://dx.doi.org/10.4254/wjh.v8.i16.691